GlassScriptPhysician profile
Maribel Montoya
NPI 1477591451
$32,737.73
in general payments reported to CMS, 2019-2025
46 companies · $1,760 in 2025
The $1,760 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $7,663 · 2021: $445 · 2022: $683 · 2023: $658 · 2024: $1,753 · 2025: $1,760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,170.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20,067.48 | 2019-2023 | Farxiga |
| Abbvie INC. | $6,236.57 | 2019-2025 | |
| Novo Nordisk INC | $994.13 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $743.95 | 2019-2025 | |
| Lilly USA, LLC | $699.47 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Medtronic, INC. | $643.74 | 2021-2025 | Minimed 780g |
| Amgen INC. | $310.82 | 2019-2025 | Evenity, Tepezza, Repatha |
| Tandem Diabetes Care, INC. | $261.77 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Radius Health, INC. | $255.76 | 2019-2025 | |
| Recordati_rare_diseases_inc. | $226.60 | 2025 | Isturisa |
| Abbott Laboratories | $224.61 | 2020-2024 | Freestyle Libre |
| Medtronic Minimed, INC. | $191.70 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $165.50 | 2024-2025 | |
| Corcept Therapeutics | $135.26 | 2019-2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $128.11 | 2022-2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maribel Montoya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.